WASHINGTON — It is the time of year every college basketball fan waits for. March Madness is right around the corner. Sixty-eight men's and women’s teams will soon have their sights on raising the ...

Recursion Pharmaceuticals (RXRX) added ~11% in the morning trading on Wednesday after J.P. Morgan upgraded the AI-driven biotech to Overweight from Neutral, citing a blockbuster sales potential for ...

At a Tuesday meeting, the Office of Residential Life announced that it will shift its program and theme housing selection process to a randomized lottery, The Herald previously reported. In the days ...

Recursion, Roche, and its Genentech subsidiary have unveiled the latest product of their nearly four-year artificial intelligence (AI) drug discovery collaboration, a whole-genome map of specialized ...

Recursion Pharmaceuticals trades at a $2.65bn valuation despite slow clinical progress, high cash burn, and no late-stage assets. RXRX's AI-driven drug discovery model is ambitious, but pipeline value ...

RXRX Price Action: Recursion Pharmaceuticals shares were up 17.21% at $6.12 at the time of publication on Wednesday, according to Benzinga Pro data. Recursion Pharmaceuticals operates in the highly ...

Defense Secretary Pete Hegseth is expressing support for the Army’s termination of a program that assessed the branch’s leadership selection process. He shared on social media platform X an image of a ...

The Army has canceled its Command Assessment Program (CAP), a promotion board that factored psychological assessments and potential biases into leadership considerations. "Good riddance," Defense ...

The Army has cut a program it used in recent years to pick officers to lead battalions and brigades and select to the top enlisted leaders for those formations, the service’s Human Resources Command ...

– Company Eligible to Receive Up to $25 Million, Including an Upfront Equity Payment of $7.5 Million – – Extends Rallybio Cash Runway to Mid-2027 – NEW HAVEN, Conn.--(BUSINESS WIRE)--Rallybio ...